KONTAN.CO.ID - JAKARTA. The weakening trend of the Indonesian rupiah against the US dollar could potentially have a significant impact on the sustainability of the pharmaceutical business in Indonesia. According to observations on the Google Finance page, the rupiah broke through the level of Rp 16,057 per US dollar on Monday (15/4) afternoon. Elfiano Rizaldi, the Executive Director of the Pharmaceutical Company Association (GP), believes that the impact of the weakening rupiah on the pharmaceutical industry greatly depends on how long this currency correction trend lasts.
Indonesian Pharmaceutical Industry to be Affected by Rupiah Depreciation
KONTAN.CO.ID - JAKARTA. The weakening trend of the Indonesian rupiah against the US dollar could potentially have a significant impact on the sustainability of the pharmaceutical business in Indonesia. According to observations on the Google Finance page, the rupiah broke through the level of Rp 16,057 per US dollar on Monday (15/4) afternoon. Elfiano Rizaldi, the Executive Director of the Pharmaceutical Company Association (GP), believes that the impact of the weakening rupiah on the pharmaceutical industry greatly depends on how long this currency correction trend lasts.